Hemophilia & Other Bleeding Disorders

Welcome to the Blood CME Center’s Hemophilia and Other Bleeding Disorders Education Center. This educational channel has been developed by experts in congenital and acquired factor deficiencies to deliver high–quality, clinically practical education to clinicians dedicated to treating patients with hemophilia and other bleeding and clotting disorders. Exclusive CME programs include interactive learning activities and personalized modular learning forums.

 
 
image
“CME/CE NetWorkShops™: Issues and Challenges in Your Hemophilia Treatment Center”
Credits: 1.0 AMA / 1.0 ANCC Expires: 11/2014
This year’s CME/CE NetWorkShops™ webcast series features leaders in hemophilia care who offer their insights on findings from national and international meetings that took place in 2013. Miguel A. Escobar, MD; Craig Kessler, MD, MACP; Thomas Loew, MD; Steven W. Pipe, MD; Doris Quon, MD, PhD; and Mark T. Reding, MD, share ideas on how to apply the latest learning of hemophilia morbidity, acquired hemophilia A, hemophilia B, and treatment strategies to their clinical practice.

image
“Enduring: The BUC Stops Here! Urgent Hematology Consultations on Bleeding of Undetermined Cause in Hospitalized Patients”
Credits: 1.25 AMA / 1.10 ANCC Expires: 3/2015
As an extension to our 2013 ASH symposium that took place on December 6, 2013, join Manuel Carcao, MD, MSc; Miguel A. Escobar, MD; and Mark T. Reding, MD, as they discuss identification, diagnosis, and management of factor VII and factor XIII deficiencies, as well as acquired hemophilia.

image
“A Clinical Case Debate Forum: Factor-Deficient Children With Intracranial Hemorrhage Identification…Treatment…Management”
Credits: 1.5 CME / 1.4 CNE Expires: 5/2014
If you are attending the Annual Meeting of the American Society of Pediatric Hematology/Oncology (ASPHO) in Chicago, please register to join us at a CME/CNE dinner symposium on Thursday, May 15, 2014, at 7:00 pm in the Empire Room of the Palmer House Hilton.

This dinner symposium brings together 3 Blood CME Center faculty experts— Amy D. Shapiro, MD; Charles Nakar, MD; and Michael Tarantino, MD—to share expert opinion and offer the latest information on current and emerging strategies and practical case reports on the identification, treatment, and management of clotting factor deficiencies that play a role in causing intracranial hemorrhage (ICH) in children.

image
“i-Build-a-Case™: Diagnosing Postpartum Acquired Hemophilia in Hospitalized Patients”
Credits: 0.75 AMA / 0.7 ANCC Expires: 1/2015
Learn more about the postpartum development of inhibitors to factor VIII and work toward saving the life of your patient who presents with unusual bleeding.

image
“Is It AH or Something Else? Unexplained Bleeding in Hospitalized Patients”
Credits: 1.0 AMA / 1.0 ANCC Expires: 11/2014
Join experts Craig Kessler, MD, MACP; Caroline Cromwell, MD; and Aryeh Shander, MD, FCCM, FCCP, in the enduring version of a live event that took place on November 21, 2013, as they discuss multiple clinical presentations of unexplained bleeding encountered in the hospital setting.

image
“The BUC Stops Here! Urgent Hematology Consultations on Bleeding of Undetermined Cause in Hospitalized Patients”
Credits: Not for credit
This satellite dinner symposium preceded the 55th ASH Annual Meeting in New Orleans and brought together Blood CME Center faculty Manuel Carcao, MD, MSc; Miguel A. Escobar, MD; and Mark T. Reding, MD. These 3 bleeding disorder experts educated hematologists and other coagulation specialists on how to consult with other healthcare providers regarding the identification, diagnosis, and management of factor VII and factor XIII deficiencies, as well as acquired hemophilia.

image
“i-Build-a-Case™: Diagnosing FXIII Deficiency in Hospitalized Patients”
Credits: 0.75 AMA / 0.7 ANCC Expires: 12/2014
In this case-based learning activity, discover the importance of pursuing hematologic testing beyond standard laboratory assessments when normal results are obtained for patients who present with persistent bleeding and a positive bleeding history.

image
eClinical Reports - Module 3: Discussion: Formulating Strategies to Improve the Quality of Life and Outcomes Among Patients With Hemophilia With Inhibitors”
Credits: 0.75 AMA / 0.7 ANCC Expires: 12/2014
Module 3 of this educational activity will provide clinicians with a comprehensive dialogue on formulating strategies to improve the quality of life and outcomes among patients with hemophilia with inhibitors.

image
eClinical Reports - Module 2: The Challenge of Managing Hemophilia in Patients With Inhibitors”
Credits: 0.75 AMA / 0.8 ANCC Expires: 11/2014
Module 2 of this educational activity will provide clinicians with a comprehensive dialogue on the challenges of managing hemophilia in patients with inhibitors.

image
“Cyberounds®: Unexplained Bleeding in Hospitalized Patients”
Credits: 1.0 AMA / 1.0 ANCC Expires: 11/2014
Given the approximately 36.5 million hospital admissions in the United States, an unexplained bleeding scenario could very well be one that you are required to manage someday. Would you know how to handle it?

image
“i-Build-a-Case™: Diagnosing Acquired Hemophilia in Hospitalized Patients”
Credits: 0.75 AMA / 0.6 ANCC Expires: 11/2014
This case-focused learning activity, presented by hematology expert Aryeh Shander, MD, FCCM, FCCP, takes participants through the diagnosis and treatment strategy for a patient who presents with unexplained bruising and bleeding.

image
eClinical Reports - Module 1: Issues of Current and Emerging Models of Prophylaxis in Hemophilia”
Credits: 0.75 AMA / 0.7 ANCC Expires: 11/2014
Module 1 of this educational activity will provide clinicians with a comprehensive dialogue on current and emerging models of prophylaxis and the debate surrounding this issue.

image
“i-Build-a-Case™: Diagnosing FVII Deficiency in Hospitalized Patients”
Credits: 0.75 AMA / 0.8 ANCC Expires: 11/2014
In this case-based learning activity, Amy D. Shapiro, MD, discusses the importance of identifying unexplained or unusual bleeding in hospitalized patients at clinical presentation and with laboratory testing.

image
“A Pediatric HEM/ONC’s Nightmare Weekend on Call: 2 Cases of Unusual Bleeding and Bruising”
Credits: 1.0 AMA / 1.0 ANCC Expires: 8/2014
Meet Brittany and Conner, 2 young patients admitted to the emergency department of a local hospital with unusual bleeding and bruising. Participate with the experts in their diagnosis and treatment.

Please disable any pop-up blockers before viewing this activity.

image
“Full House at the San Francisco Hemophilia Treatment Center CME/CE NetWorkShops™”
Credits: Not for credit
May 14th proved to be a bustling evening at Ruth’s Chris Steak House, where 47 physicians, nurses, pharmacists, and physical therapists gathered to hear Dr. Benjamin Kim speak for the San Francisco hemophilia treatment center (HTC) CME/CE NetWorkShops™. Continue to read the full blog and hear first-hand from our staff writer who attended the live presentation in San Francisco.

image
“HTC CME/CE NetWorkShops™ Webcast: Patient Management Challenges in Your Hemophilia Treatment Center”
Credits: 1.0 AMA / 1.0 ANCC Expires: 6/2014
This year’s CME/CE NetWorkShops™ Webinar series features leaders in hemophilia care who offer their insights on findings from national and international meetings that took place in 2012. In this Webinar from the live series, Ellis Neufeld, MD, PhD, discusses new challenges in hemophilia, inhibitor risk development, ITI, treatment adherence, cost, PT and elective orthopedic surgery, and pain management.

image
“Clinical Challenges in Your Hemophilia Treatment Center”
Credits: 1.0 CME / 1.0 CNE Expires: 5/2014
As part of the 2012 CME/CE NetWorkShops™ Webinar series, hemophilia experts Miguel Escobar, MD; Patrick Fogarty, MD; Mark Reding, MD; Tammuella Singleton, MD; and Leonard Valentino, MD, provide their insights on current issues and practices in hemophilia care.

image
“World Hemophilia Day 2013: What’s To Celebrate?”
Credits: Not for credit
April 17 is World Hemophilia Day, an annual event started by the World Federation of Hemophilia (WFH) to unite the global bleeding disorders community in raising awareness about hemophilia and other related bleeding disorders. This year’s event has special significance because it marks 50 years of advancing the cause for the treatment and care of all individuals with hemophilia and rare bleeding disorders.

image
“Update on Rare Bleeding Disorders: Clinical Presentation, Diagnostic Evaluation, and Treatment”
In this learning activity, noted Blood CME Center faculty David Green, MD, PhD; Maureane Hoffman, MD, PhD; and Flora Peyvandi, MD, PhD share their perspectives on the rare coagulation deficiencies in a discussion that addresses the physiology of coagulation and the role of clotting factors, as well as the epidemiology, clinical presentation, and treatment of RBDs.

image
“Physical Therapy in Patients With Hemophilia: Helpful Tips for Clinicians”
Credits: Not for credit
Angela Forsyth, PT, DPT, discusses the distinguishing aspects of physical therapy in patients with hemophilia and hemophilia with inhibitors, while offering advice to clinicians who may not routinely treat this patient population. As part of the activity, Dr. Forsyth conducts a physical assessment of the knee joint, focusing on swelling, crepitus on motion, and flexion and extension loss.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this activity:

Consulting Fees: Novo Nordisk Inc.; Fees for Non-CME Services Received Directly From a Commercial Interest or Their Agents: Bayer Healthcare

image
“Hemophilia Clinical Consults: Epidemiology, Clinical Course, and Management of Acquired Hemophilia A”
Credits: 1.0 CME / 1.0 CNE
The incidence of acquired hemophilia A occurs between approximately 1.34 and 1.48 per 1 million per year and predominantly affects older patients. Due to the subcutaneous, muscle, or gastrointestinal bleeding that presents with the disease, specialty physicians need to be aware of possible clinical presentations and treatment options. In this case-based learning activity, Craig Kessler, MD, and Mariasanta Napolitano, MD, both from the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center in Washington, DC, discuss the pathogenesis and treatment of acquired hemophilia A and engage in a Q&A exchange regarding various clinical presentations and diagnoses.

image
“STAT: An Interactive Learning Activity About Bleeding Disorders and Coagulation Deficiencies for EM Residents”
Credits: Not for credit
Patients with coagulation deficiencies, either congenital or acquired, may bleed spontaneously with either trauma or surgical intervention. Additionally, patients with unknown bleeding disorders not treated at hemophilia treatment centers usually seek immediate care from an emergency room. In a symposium held in conjunction with the Society for Academic Emergency Medicine Annual Meeting, Peter Kouides, MD; David Green, MD; Thomas Ortel, MD, PhD; Michael Paidas, MD; and Mark Walsh, MD, discussed several topics pertinent to EM residents who may encounter bleeding disorders. Topics included the epidemiology and clinical characteristics of adult bleeding disorders, coagulation tests and assays, taking a bleeding history, platelet function testing, and the female bleeding patient in the emergency room.

image
“Clinical Decisions in the Emergency Department: Pros and Cons of Managing Oral Anticoagulant-Associated Hemorrhages and Acute Traumatic Coagulopathy”
Credits: Not for credit
Widespread use of anticoagulants has led to an increase in bleeding episodes seen in emergency departments. The best strategy for reversal of coaguloathy associated with warfarin-related bleeding is still under debate. In a dinner symposium held in conjunction with the Annual Meeting of the Society for Academic Emergency Medicine, W. Frank Peacock, MD; Bryan A. Cotton, MD, MPH; and David A. Garcia, MD, discussed the interpretation of current coagulation assays and their impact on clinical decisions; best practices for the rapid reversal of anticoagulant-associated intracerebral hemorrhage; and the reversal of acute traumatic coagulopathy in patients presenting to the emergency department.

image
“Current Strategies for the Surgical Management of Patients With Congenital Bleeding Disorders”
Credits: Not for credit
Patients with congenital bleeding disorders are at risk for poor outcomes due to the clinical challenges present during surgical procedures. In a dinner symposium held in conjunction with the 2011 ASPHO (American Society of Pediatric Hematology/Oncology) Annual Meeting, Victor S. Blanchette, MD, FRCP, Head of the Division of Hematology/Oncology at the Hospital for Sick Children; Steven W. Pipe, MD, Associate Professor of Pediatrics and Pathology at C.S. Mott Children’s Hospital, University of Michigan; and Meera B. Chitlur, MD, Assistant Professor, Division of Pediatric Hematology/Oncology at Children’s Hospital of Michigan, present on issues pertaining to the perioperative management of patients with congenital bleeding disorders. As part of their discussion, these noted experts address hemophilic and non-hemophilic inhibitors of coagulation, standard and emerging coagulation tests, and novel and experimental clotting factors.

image
“Practical Strategies for Managing Hemophilia and Preventing Inhibitor Development”
Credits: Not for credit
The goal of hemophilia therapy is to treat and prevent bleeding episodes and related complications, such as inhibitor development, by replacing the deficient clotting factor. In this learning activity, bleeding disorder expert Leonard A. Valentino, MD, assesses the benefits and risks of plasma-derived and recombinant factor replacement therapies and examines effective inhibitor prevention strategies, including prophylaxis and the avoidance of immunological danger signals.

image
“Management of High-Titer FVIII Inhibitors”
Credits: Not for credit
In this activity, Michael Recht, MD, PhD, explores the efficacy of prophylactic bypassing therapies in hemophilia A patients with inhibitors and examines evidence from comparative trials of FEIBA and rFVIIa as on-demand treatment in this patient cohort.

image
“Elective Orthopedic Surgery in Patients With Inhibitors: Preoperative and Postoperative Care”
Credits: Not for credit
What type of care is required of hemophilia A patients with inhibitors who elect to undergo orthopedic surgery? A nurse and a physical therapist discuss the preoperative and postoperative challenges such patients present to the hemophilia treatment center team. Issues addressed in this podcast include the importance of patient education, dosing of bypassing agents, calculation of factor requirements, preoperative and postoperative exercise programs, and the importance of physical therapy in the surgical patient’s rehabilitative process. An actual patient with inhibitors provides his viewpoint on the orthopedic surgery he has had and discusses his concerns, rehabilitation program, and quality-of-life issues.

Ref No Description
     
037 Management of Bleeding Episodes in Patients With Hemophilia and Inhibitors to Reduce Complications and Minimize Joint Damage Case-based learning activity focused on acute and long-term care of patients with hemophilia and inhibitors
036 Identification, Diagnosis, and Management of Acquired Hemophilia A (AHA) Management of Acquired Hemophilia A (AHA)
035 Prophylactic Bypassing Therapy in Pediatric Inhibitor Patients to Avoid Musculoskeletal Complications Prophylactic Bypassing Therapy in Pediatric Inhibitor Patients
034 Acute and Chronic Pain in Hemophilia Patients Panel discussion on Acute and Chronic Pain in Hemophilia Patients
033 Prophylactic Bypassing Therapy in Adult Hemophilia Patients Undergoing Orthopedic Surgery Panel discussion on prophylactic bypassing therapy in adult hemophilia patients who undergo orthopedic surgery
032 Hemophilia Experts Video Summit: How We Manage the Musculoskeletal Complications of Hemophilia in Pediatric Patients Panel discussion on managing the musculoskeletal complications of hemophilia in pediatric patients
031 Hemophilia Experts Video Summit: How We Manage the Musculoskeletal Complications of Hemophilia in Adult Patients Panel discussion on managing the musculoskeletal complications of hemophilia in adult patients
030 Physical Therapy in Patients With Hemophilia: Helpful Tips for Clinicians: (PT Video) Advice for clinicians about PT in hemophilia patients
029 Clinical Challenges in Your Hemophilia Treatment Center Learning activity addresses clinical challenges in hemophilia treatment centers
028 The Aging Hemophilia Patient: Comorbidities and Management Issues Learning activity concerning management issues of the aging hemophilia patient
026 Hemophilia Clinical Consults: Epidemiology, Clinical Course, and Management of Acquired Hemophilia A Interactive, case-based learning activity regarding the epidemiology, clinical presentation, and management of patients with acquired hemophilia A
025 Hemophilia Clinical Consults: Hemophilic Arthropathy, Reduced Bone Density, and Preventive Strategies Case-based learning activity exploring preventive strategies for hemophilic arthropathy, and clinical characteristics
024 Transitioning From Pediatric to Adult Hemophilia Care: Managing Lifestyle and QoL Challenges Learning activity concerning the transition from pediatric to adult hemophilia care
023 Hemophilia Clinical Consults: Inhibitor Formation, Management, and Therapeutic Options Case-based, interactive learning activity exploring the natural history of inhibitors and available management and therapeutic options
022 Hemophilia Clinical Consults: Therapeutic Decisions in the Perioperative Management of Patients With Hemophilia A Undergoing Surgery Case-based learning activity exploring surgical procedures in hemophilia A patients and factors to consider during perioperative management
021 Practical Strategies for Managing Hemophilia and Preventing Inhibitor Development Clinical Insight featuring discussion of inhibitor prevention and treatment strategies in hemophilia
020 Prophylaxis in Hemophilia Patients Without Inhibitors and Its Impact on Inhibitor Development Presentation on the impact of prophylaxis on inhibitor development and its use in hemophilia patients without inhibitors
019 Prophylaxis in Hemophilia: Do Immunologic Danger Signals or Pharmacokinetics Hold Relevance? Presentation on prophylaxis and potential immunologic triggers of inhibitor development
018 HTC CME NetWorkShopsTM: Current Issues and Trends in Hemophilia Care Learning activity concerning issues and trends in hemophilia treatment centers
017 Early Prophylaxis and the Influence of Immunologic ‘Danger Signals’ on Inhibitor Development Learning activity concerning immunologic “danger signals” and the effects of early prophylaxis on inhibitor development
016 Pathophysiology of Joint Bleeding and Synovitis: The Impact on Joint Health Learning activity on the impact of joint bleeding and synovitis on joint health.
015 Safe Use of Radiosynovectomy for Chronic Hemophilic Synovitis Learning activity on the safety issues associated with radiosynovectomy for treating hemophilic synovitis
014 Treatment Decisions and Clinical Outcomes in Hemophilia B Patients With Inhibitors Presentation on treatment decisions and clinical outcomes for inhibitor patients with FIX deficiency
013 FIX Deficiency and Inhibitors: Report From the ISTH-SSC International Registry Learning activity concerning the ISTH-SSC International Registry and hemophilia B with inhibitors
012 Clinical Challenges in Your Hemophilia Treatment Center Learning activity concerning clinical challenges in hemophilia treatment centers
011 Management of High-Titer FVIII Inhibitors Learning activity on managing FVIII inhibitors in hemophilia A patients.
010 Radiosynovectomy in Hemophilia Learning activity concerning the use of radiosynovectomy as a treatment for hemophilic synovitis.
009 The Nurse Coordinator’s Perspective on Managing Hemophilia Patients With Inhibitors Clinical Insight featuring discussion of the nurse coordinator’s role in hemophilia care and managing hemophilia patients with inhibitors
008 Perspectives in Hemophilia: Clinical Challenges and Current Issues in Managing Patients With Inhibitors Learning activity concerning clinical challenges in managing hemophilia patients with inhibitors.
007 Expert Opinion: The Clinical Importance of Adhering to Preventive PT Regimens for Minimizing Joint Damage Presentation on the benefits of PT for hemophilia patients
006 Hemophilia Consults: Should Patients With Inhibitors Receive Prophylaxis With Bypassing Agents? Learning activity concerning use of prophylactic bypassing therapy in hemophilia patients with inhibitors.
005 Perspectives in Hemophilia: Clinical Challenges and Current Issues in Managing Patients With Inhibitors Presentation from the 2010 American Society of Pediatric/Hematology/Oncology Annual Meeting
003 Elective Orthopedic Surgery in Patients With Inhibitors: The Hematologist/Orthopedic Surgeon Consult Expert commentary on orthopedic surgery in hemophilia A patients with inhibitors
002 Elective Orthopedic Surgery in Patients With Inhibitors: Preoperative and Postoperative Care Preoperative and postoperative care of hemophilia A patients with inhibitors
001 Elective Orthopedic Surgery in Patients With Inhibitors: Preoperative and Postoperative Care Preoperative and postoperative care of hemophilia A patients with inhibitors

 

 

 

Link to PIM Link to CMH Link to PIM Link to CMH Link to PIM Link to CMH Link to CMH Link to PIM Link to CMH Link to CMH register Eval Subscribe Hemophilia Bleeding Disorders Journal Club RSS Feed Hemophilia/Bleeding Disorders Journal Club Home